Ligand validation:6JZ2

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JZ2_MRD_B_704	51%	65%	0.108	0.86	0.64	0.71	-	-	0	0	100%	1
6JZ2_MRD_B_702	28%	71%	0.137	0.79	0.62	0.5	-	-	0	0	100%	1
6JZ2_MRD_A_702	5%	67%	0.263	0.681	0.75	0.52	-	-	1	0	100%	1
6JZ4_MRD_A_702	24%	37%	0.271	0.903	1.27	1.2	1	1	1	0	100%	1
6JZ3_MRD_B_702	22%	37%	0.214	0.831	1.54	0.97	1	-	3	0	100%	1
7EK9_MRD_A_201	97%	88%	0.06	0.977	0.29	0.38	-	-	0	0	100%	1
4YZA_MRD_A_208	97%	60%	0.056	0.972	0.37	1.15	-	1	0	0	100%	0.91
4MKN_MRD_A_306	97%	67%	0.068	0.98	0.4	0.85	-	-	0	0	100%	0.5
3GZB_MRD_G_156	96%	70%	0.066	0.973	0.43	0.73	-	-	0	0	100%	1
4IIC_MRD_A_940	95%	53%	0.064	0.966	1.34	0.49	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.